Anzhalika Sidarovich

764 total citations
8 papers, 332 citations indexed

About

Anzhalika Sidarovich is a scholar working on Infectious Diseases, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Anzhalika Sidarovich has authored 8 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 2 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Anzhalika Sidarovich's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 detection and testing (2 papers). Anzhalika Sidarovich is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 detection and testing (2 papers). Anzhalika Sidarovich collaborates with scholars based in Germany. Anzhalika Sidarovich's co-authors include Markus Hoffmann, Luise Graichen, Stefan Pöhlmann, Prerna Arora, Hans‐Martin Jäck, Nadine Krüger, Sebastian Schulz, Amy Kempf, Anna-Sophie Moldenhauer and Inga Nehlmeier and has published in prestigious journals such as PLoS ONE, Journal of Virology and Cell Host & Microbe.

In The Last Decade

Anzhalika Sidarovich

8 papers receiving 331 citations

Peers

Anzhalika Sidarovich
Kaitlin R. Sprouse United States
Ryan G. Casner United States
Anshu Joshi United States
Anna J. MacCamy United States
Erik Boehm Switzerland
Azra Lari United States
Jérémy Campos Switzerland
Rachael E. Whaley United States
Krishna Anand United States
Kaitlin R. Sprouse United States
Anzhalika Sidarovich
Citations per year, relative to Anzhalika Sidarovich Anzhalika Sidarovich (= 1×) peers Kaitlin R. Sprouse

Countries citing papers authored by Anzhalika Sidarovich

Since Specialization
Citations

This map shows the geographic impact of Anzhalika Sidarovich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anzhalika Sidarovich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anzhalika Sidarovich more than expected).

Fields of papers citing papers by Anzhalika Sidarovich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anzhalika Sidarovich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anzhalika Sidarovich. The network helps show where Anzhalika Sidarovich may publish in the future.

Co-authorship network of co-authors of Anzhalika Sidarovich

This figure shows the co-authorship network connecting the top 25 collaborators of Anzhalika Sidarovich. A scholar is included among the top collaborators of Anzhalika Sidarovich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anzhalika Sidarovich. Anzhalika Sidarovich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Arora, Prerna, Lu Zhang, Inga Nehlmeier, et al.. (2025). Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D. Journal of Virology. 99(2). e0123024–e0123024. 1 indexed citations
2.
Sidarovich, Anzhalika, Nadine Krüger, Cheila Rocha, et al.. (2022). Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1. Viruses. 14(11). 2475–2475. 1 indexed citations
3.
Arora, Prerna, Anzhalika Sidarovich, Luise Graichen, et al.. (2022). Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein. PLoS ONE. 17(3). e0265453–e0265453. 9 indexed citations
4.
Arora, Prerna, Lu Zhang, Nadine Krüger, et al.. (2022). SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies. Cell Host & Microbe. 30(8). 1103–1111.e6. 29 indexed citations
5.
Hoffmann, Markus, Anzhalika Sidarovich, Prerna Arora, et al.. (2022). Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy. mBio. 13(3). e0036422–e0036422. 22 indexed citations
6.
Hoffmann, Markus, Heike Hofmann-Winkler, Nadine Krüger, et al.. (2021). SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Reports. 36(3). 109415–109415. 162 indexed citations
7.
Arora, Prerna, Anzhalika Sidarovich, Nadine Krüger, et al.. (2021). B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell Reports. 37(2). 109825–109825. 56 indexed citations
8.
Sidarovich, Anzhalika, Cindy L. Will, Maria Anokhina, et al.. (2017). Identification of a small molecule inhibitor that stalls splicing at an early step of spliceosome activation. eLife. 6. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026